An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will review what clinical services are necessary for preventing cardiovascular conditions among women to reduce pregnancy-related morbidity and mortality. In conducting this work, the committee will identify gaps in recommended services and screenings for women, including interventions identified as effective in recent research. The committee’s recommendations will not include specific services already graded A or B by the U.S. Preventive Services Task Force or included in current Health Resources and Services Administration (HRSA)-supported Women’s Preventive Services Guidelines but may include enhancements to them. Specifically, the committee will consider the following questions:

• What services and screenings are needed to fill gaps in recommended women’s preventive services in order to better address cardiovascular disease and associated risk factors such as hypertension among women of reproductive age, during pregnancy, and post-partum?
• Are there considerations associated with the timing of these services (e.g., before, during, and after pregnancy)?
• Are there considerations about which services and screenings should apply to women at different stages of life (e.g., all reproductive age women) and/or women at different levels of risk for cardiovascular disease?

In addition to providing actionable recommendations for services and screenings the committee will respondto the following questions:

• How can various HRSA programs mitigate or eliminate barriers pertaining to accessibility, provision, uptake, and/or utilization of these services for the prevention of cardiovascular disease among women?
• What research on promising but not yet conclusive interventions could be supported to close identified evidence gaps in recommended services and screenings for cardiovascular disease among women?